Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.40 +0.41 (+2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Return on Assets [ROA] (2014 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) posted Return on Assets [ROA] of -41.47% for Q2 2026, up 13.80 percentage points from -55.27% a year earlier and up 1.86 percentage points from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Viridian Therapeutics, Inc.\DE's Return on Assets [ROA] came in at -41.53%, up 2.21 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +95.78 percentage points (FY2020 to FY2025).
  • In prior years, Viridian Therapeutics, Inc.\DE's Return on Assets [ROA] was -43.74% in FY2024 (+7.59 pp), -51.33% in FY2023 (-10.67 pp), -40.66% in FY2022 (+6.75 pp) and -47.42% in FY2021 (+89.89 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q4 2024.
  • On a year-over-year basis, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of +1.87 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2021, with a gain of 97.75 percentage points; the weakest was Q4 2023, with a drop of 28.33 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -43.33% (Q1 2026), -46.18% (Q4 2025) and -52.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Viridian Therapeutics, Inc.\DE 2.20 Bn 2.20 Bn - -41.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.47%
Mar 31, 2026 -43.33%
Dec 31, 2025 -46.18%
Sep 30, 2025 -52.12%
Jun 30, 2025 -55.27%
Mar 31, 2025 -43.87%
Dec 31, 2024 -35.59%
Sep 30, 2024 -37.82%
Jun 30, 2024 -37.48%
Mar 31, 2024 -38.89%
Dec 31, 2023 -57.99%
Sep 30, 2023 -63.70%
Jun 30, 2023 -53.62%
Mar 31, 2023 -41.94%
Dec 31, 2022 -29.66%
Sep 30, 2022 -37.04%
Jun 30, 2022 -55.63%
Mar 31, 2022 -44.79%
Dec 31, 2021 -37.40%
Sep 30, 2021 -83.26%
API Access

Viridian Therapeutics, Inc.\DE Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=VRDN&period=max&api_key=YOUR_API_KEY